- Two prestigious healthcare awards highlight Brainomix’s milestone achievements in 2024 and validation of its software’s impact on treatment rates
OXFORD, England And CHICAGO, November 29, 2024 /PRNewswire/ — Brainomix, a pioneer in artificial intelligence (AI) imaging solutions, has received the LSX European Lifestars Award for “Healthtech Company of the Year” from HSBC Innovation Banking, and for “Healthcare Company of the most transformative health technologies of the year”. by OBN.
Both awards, both highly competitive and prestigious, involved nominations from dozens of the world’s leading health technology innovators. The judges recognized the scale of Brainomix’s success over the past year, including approval from the National Institute for Health & Care Excellence (NICE) and a series of FDA clearances in the areas of accident stroke and pulmonary fibrosis, which led to the company’s expansion into the US market, and also the transformative impact of technology on patient care.
“We are honored to be recognized by LSX and OBN for these prestigious awards, which reflect the transformative impact of our technology on patient care globally,” said Doctor Michalis PapadakisCEO and co-founder of Brainomix. “We remain committed to providing cutting-edge AI solutions that will facilitate faster diagnosis and expand access to life-saving treatments for patients with stroke and pulmonary fibrosis. »
Largest real-world assessment of AI stroke imaging, presented in May at the European Stroke Organization (ESOC) conference in Baselshowed that Brainomix 360 Stroke was associated with a 50% greater increase in the number of patients undergoing mechanical thrombectomy. Mechanical thrombectomy is a revolutionary stroke treatment that can reduce disability and prevent or limit long-term care needs in patients with the most severe strokes due to blockage of a large supplying blood vessel. the brain.
Evidence of this impact has also been seen at the national level, with the deployment of Brainomix software across the country in Wales And Hungaryserving all stroke centers within their respective health systems.
“Now deployed on 28 sites in Hungarywe have seen the thrombectomy rate increase by over 50%,” said Professor István SzikoraNational Institute of Mental Health, Neurology and Neurosurgery (OMIII), Budapest. “Brainomix 360 Stroke has proven to be an extremely effective asset in improving the efficiency of stroke care in Hungary“.
Wales reported similar results, with a noted increase in thrombectomies of more than 44%. “The Brainomix 360 Stroke platform is a game changer in stroke care, generating critical information from simple brain scans and providing a secure platform for clinicians to share information, images and analytics. » Doctor Shakeel Ahmadnational clinical lead for stroke. “This allows us to make faster and more accurate decisions, which will improve the quality of care and outcomes for stroke patients, no matter where they live.” Wales“.
About Brainomix
Brainomix specializes in creating AI-based software solutions to enable precision medicine enabling better treatment decisions in stroke and pulmonary fibrosis. Coming from a spin-out from the University of OxfordBrainomix is a growing trading company with offices in the UK, Ireland and the USAand operations in more than 30 countries. Privately held, backed by leading health technology investors, Brainomix has pioneered award-winning imaging biomarkers and software solutions that have been clinically adopted in hundreds of hospitals around the world. Its first product, the Brainomix 360 platform, provides clinicians with the most comprehensive stroke imaging solution, leading to increased treatment rates and improving patients’ functional independence.
To learn more about Brainomix and its technology, visit www.brainomix.comand follow us Twitter, LinkedIn And Facebook.
Photo: https://mma.prnewswire.com/media/2569446/Brainomix.jpg
SOURCE Brainomix
YOU WANT THE NEWS OF YOUR COMPANY FEATURED ON PRNEWSWIRE.COM?
440,000+
Press rooms and
Influencers
9k+
Digital media
Points of sale
270,000+
Journalists
Registration